Monopar Therapeutics Inc. · NASDAQ:MNPR

Robinson Chandler exercised options for 9,801 Monopar Therapeutics Inc. shares (Form 4)

Traded Sep 30, 2026 · Filed Oct 2, 2026

On Sep 30, 2026, Robinson Chandler (Director, Chief Executive Officer) exercised options for 9,801 Monopar Therapeutics Inc. shares, leaving 104,724 shares. Filed Oct 2, 2026 (Form 4).

Options exercised
9,801 shares
Holding after
104,724 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 30, 2026Common StockOption exercise9,801109,068Direct
Sep 30, 2026Common StockShares withheld for tax4,344US$79.67104,724Direct

Source

View original at SEC

Related